Skip to content

Accuracy analysis of Helicobacter pylori C13 and C14 breath test

Accuracy analysis of Helicobacter pylori C13 and C14 breath test

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000041570
Enrollment
Unknown
Registered
2020-12-29
Start date
2017-01-02
Completion date
Unknown
Last updated
2021-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter pylori infection

Interventions

Gold Standard:histopathology examination
Index test:C13,&#32
C14&#32
test

Sponsors

Shenzhen Kuichong People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Subjects ged 18–70 years and sign the informed consent.

Exclusion criteria

Exclusion criteria: The exclusion criteria were having had previous treatment for H.pylori infection, or having taken a proton pump inhibitor, H2 receptor antagonist, expectorant, or antibiotic treatment within the last four weeks prior to endoscopy, past history of gastric surgery, or having been diagnosed with gastrointestinal cancer, severe heart, lung, liver, kidney or blood system disorders.

Design outcomes

Primary

MeasureTime frame
Histopathology examination for Helicobacter infection;C13, C14 urea breath test;SEN, SPE, ACC, AUC of ROC;

Countries

China

Contacts

Public ContactYongsheng He

Shenzhen Kuichong People's Hospital

1933418841@qq.com+86 13556862190

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 22, 2026